申请人:Abelman Matthew
公开号:US20100113514A1
公开(公告)日:2010-05-06
The present invention relates to sodium channel inhibitors of Formula :
in which R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, and R
7
are as defined above, and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes.
本发明涉及Formula的钠通道抑制剂:其中R1、R2、R3、R4、R5、R6和R7如上定义,并其在治疗各种疾病状态中的应用,包括心血管疾病和糖尿病。